Peters, Solange; Dafni, Urania; Boyer, Michael; De Ruysscher, Dirk; Faivre-Finn, Corinne; Felip, Enriqueta; Garrido, Pilar; Girard, Nicolas; Guckenberger, Matthias; Haanen, John; Le Pechoux, Cecile; Mornex, Francoise; Ozsahin, Mahmut; Paz-Ares, Luis; Planchard, David; Raben, David; Ramalingam, Suresh; Reck, Martin; Smit, Egbert; Stahel, Rolf; Stenzinger, Albrecht; Swanton, Charlie; Vallone, Stefania; Garassino, Marina C (2019). Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III Non-Small Cell Lung Cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP). Annals of Oncology, 30(2):161-165.
Statistics
Citations
Dimensions.ai Metrics
Altmetrics
Downloads
Additional indexing
| Item Type: | Journal Article, refereed, further contribution |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Radiation Oncology
04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology and Hematology |
| Dewey Decimal Classification: | 610 Medicine & health |
| Scopus Subject Areas: | Health Sciences > Hematology
Health Sciences > Oncology |
| Language: | English |
| Date: | 1 February 2019 |
| Deposited On: | 12 Feb 2019 15:37 |
| Last Modified: | 06 Jun 2022 07:12 |
| Publisher: | Oxford University Press |
| ISSN: | 0923-7534 |
| OA Status: | Hybrid |
| Free access at: | Publisher DOI. An embargo period may apply. |
| Publisher DOI: | https://doi.org/10.1093/annonc/mdy553 |
| PubMed ID: | 30624547 |
Peters, Solange